Immuron Ltd-spon Adr (IMRN) — Who's Buying and Selling (13F, Q2 2026)

IMRN ranks #11354 out of 37503 tracked stocks by institutional interest, inside the more closely watched half of our coverage.

IMRN is a disclosed holding of Ken Griffin (Citadel Advisors LLC), one of the tracked superinvestors on AlphaSMO — it makes up 0.0% of that fund's own 13F portfolio.

6 institutions disclose a position in IMRN, but none treat it as a major bet — even Citadel Advisors LLC, its most concentrated holder, allocates just 0.0% of its own portfolio to it.

BNP Paribas Financial Markets has added to its IMRN position for two straight quarters, increasing it by $5.5K to reach $5.5K today.

Morgan Stanley has trimmed its IMRN position for two straight quarters, cutting it by $42.0K while still holding $1.8K.

IMRN reported a net loss of $5.2M in its latest fiscal year.

• Not yet profitable — net loss of $5.2M in the latest fiscal year
• Revenue grew 48.6% year over year
• Net income improved year over year, from -$6.9M to -$5.2M
• Operating cash flow was negative, using $6.1M in cash
• Current ratio of 5.09x — enough short-term assets to cover short-term liabilities
• Liabilities run 0.26x equity — within a conventional range